EGM
HBIO icon

Engineers Gate Manager’s Harvard Bioscience HBIO Stock Holding History

Engineers Gate Manager’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,920
Closed -$51.6K – 2367
2024
Q3 		$51.6K Buy
1,920
+113
+6% +$3.33K ﹤0.01% 1978
2024
Q2 		$51.5K Sell
1,807
-8
-0.4% -$281 ﹤0.01% 1811
2024
Q1 		$77K Sell
1,815
-302
-14% -$13.6K ﹤0.01% 1771
2023
Q4 		$113K Sell
2,117
-847
-29% -$38.2K ﹤0.01% 1756
2023
Q3 		$127K Sell
2,964
-4,484
-60% -$207K ﹤0.01% 1571
2023
Q2 		$409K Buy
7,448
+5,953
+398% +$327K 0.02% 1152
2023
Q1 		$62.8K Sell
1,495
-347
-19% -$10.3K ﹤0.01% 1547
2022
Q4 		$51K Sell
1,842
-454
-20% -$11.2K ﹤0.01% 1549
2022
Q3 		$59K Sell
2,296
-11,428
-83% -$378K ﹤0.01% 1489
2022
Q2 		$494K Buy
13,724
+7,750
+130% +$350K 0.02% 1117
2022
Q1 		$371K Buy
5,974
+1,835
+44% +$109K 0.01% 1246
2021
Q4 		$292K Sell
4,139
-504
-11% -$35.8K 0.01% 1422
2021
Q3 		$324K Sell
4,643
-2,537
-35% -$202K 0.02% 1143
2021
Q2 		$598K Buy
7,180
+3,595
+100% +$254K 0.04% 730
2021
Q1 		$196K Buy
3,585
+2,197
+158% +$107K 0.01% 1607
2020
Q4 		$60K Buy
1,388
+25
+2% +$933 ﹤0.01% 1626
2020
Q3 		$41K Sell
1,363
-642
-32% -$21.6K ﹤0.01% 1614
2020
Q2 		$62K Buy
+2,005
New +$54K ﹤0.01% 1623
2020
Q1 		– Sell
-1,484
Closed -$45K – 1712
2019
Q4 		$45K Sell
1,484
-801
-35% -$23K ﹤0.01% 1569
2019
Q3 		$70K Sell
2,285
-2,606
-53% -$64.8K ﹤0.01% 1325
2019
Q2 		$98K Buy
4,891
+3,301
+208% +$96.7K 0.01% 1061
2019
Q1 		$69K Sell
1,590
-48
-3% -$1.74K ﹤0.01% 888
2018
Q4 		$52K Sell
1,638
-497
-23% -$19.6K ﹤0.01% 840
2018
Q3 		$112K Buy
+2,135
New +$120K 0.01% 854

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Engineers Gate Manager's HBIO Position: Q4 2024 in Review

Engineers Gate Manager sold out of Harvard Bioscience (HBIO) in Q4 2024, closing a stake of 1,920 shares — an estimated $51.6K sold.

Engineers Gate Manager first reported a position in HBIO in Q3 2018 and held it in 24 quarters. The position peaked at $598K in Q2 2021. 95 funds tracked by Wall St. Rank hold HBIO as of Q4 2024.

  • Engineers Gate Manager reported no remaining Harvard Bioscience position as of Q4 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 1,920 Harvard Bioscience shares in Q4 2024, an estimated $51.6K.
  • Engineers Gate Manager first reported a position in Harvard Bioscience in Q3 2018 and held it in 24 quarters.
  • Engineers Gate Manager's Harvard Bioscience position peaked at $598K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2024.

Based on Engineers Gate Manager's 13F filing for Q4 2024, filed 14 Feb 2025.